Sweet Syndrome Successfully Treated With Ruxolitinib in JAK-2 Positive Myeloproliferative Disorder

doi 10.23937/iaim-2017/1710008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

ClinMed International Library

Related search

ETV6–FLT3 Fusion Gene-Positive, Eosinophilia-Associated Myeloproliferative Neoplasm Successfully Treated With Sorafenib and Allogeneic Stem Cell Transplant

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2014English

A Patient With Fechtner Syndrome Successfully Treated With Romiplostim

Thrombosis and Haemostasis
Hematology
2012English

Post‐allogeneic Transplant Evans Syndrome Successfully Treated With Daratumumab

British Journal of Haematology
Hematology
2019English

Hemolytic Uremic Syndrome-Associated Encephalopathy Successfully Treated With Corticosteroids

Internal Medicine
Internal MedicineMedicine
2017English

Transient Myeloproliferative Disorder in Neonates With Down Syndrome: Case Report and Review

Journal of Down Syndrome & Chromosome Abnormalities
2018English

JAK Inhibition With Ruxolitinib Versus Best Available Therapy for Myelofibrosis

New England Journal of Medicine
Medicine
2012English

Touraine-Solente-Gole Syndrome With Acne Vulgaris Successfully Treated With Isotretinoin

Journal of Dermatology & Cosmetology
2018English

Pairing JAK With MEK for Improved Therapeutic Efficiency in Myeloproliferative Disorders

Journal of Clinical Investigation
Medicine
2019English

First Case of Congenital Myeloproliferative Disorder in a Newborn Diagnosed With Noonan Syndrome

Journal of Neonatal Biology
2015English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy